Latham & Watkins advised Cadence, and Wilson Sonsini Goodrich & Rosati advised Rambus on the transaction. Cadence Design Systems, Inc. and Rambus Inc. announced that they have entered...
Cadence’s Acquisition of Rambus PHY IP Assets
Novartis’ Acquisition of DTx Pharma
Wilson Sonsini Goodrich & Rosati is advising DTx Pharma on the transaction. A preclinical-stage biotechnology company, DTx Pharma announced that it has been acquired by Novartis. In addition...
Pyxis Oncology’s Acquisition of Apexigen
Sidley Austin LLP advised Pyxis Oncology, Inc. on the transaction, while Wilson Sonsini advised Apexigen on the transaction. Pyxis Oncology, Inc., a clinical-stage company, and Apexigen,...
Pacific Biosciences’ $201.25 Million Stock Offering
Wilson Sonsini advised Pacific Biosciences of California on the offering, and Davis Polk advised the representatives of the several underwriters involved. Pacific Biosciences of California Inc. announced...
Bruker’s Acquisition of Inscopix
Wilson Sonsini Goodrich & Rosati advised Inscopix on the deal. Bruker Corporation, a developer, manufacturer, and distributor of high-performance scientific instruments and analytical and diagnostic solutions,...
DroneDeploy’s Acquisition of StructionSite
Wilson Sonsini Goodrich & Rosati advised DroneDeploy on the transaction while Sidley represented StructionSite. DroneDeploy, the leading aerial reality capture platform, announced that it has entered...
Roblox’s Acquisition of Byfron
Wilson Sonsini advised Roblox on the deal. Roblox announced it has acquired Byfron, a leader in anti-cheat solutions. Byfron has developed a state-of-the-art anti-cheat solution that...
Boston Scientific’s Acquisition of Obsidio
Wilson Sonsini Goodrich & Rosati advised Obsidio on the deal, while Latham & Watkins represented Boston Scientific Corporation. Boston Scientific Corporation announced the acquisition of Obsidio, Inc.,...
Novartis’ Acquisition of Kedalion Therapeutics
Wilson Sonsini advised Kedalion Therapeutics on the deal. Novartis announced that it acquired Kedalion Therapeutics and its AcuStream technology, an innovative device that may have the...
LinkedIn’s Acquisition of EduBrite
Wilson Sonsini Goodrich & Rosati advised LinkedIn on the deal. LinkedIn announced that it entered into an agreement to acquire EduBrite, a platform that specializes in...
Kensington Capital Acquisition Corp. IV’s Merger With Amprius Technologies
Hughes Hubbard & Reed represented Kensington Capital Acquisition Corp. IV in the transaction while Wilson Sonsini represented Amprius Technologies. Kensington Capital Acquisition Corp. IV executed its business...
Apexigen’s Business Combination Agreement with Brookline Capital Acquisition Corp.
Wilson Sonsini advised Apexigen on the deal. Apexigen, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing a new generation of antibody therapeutics for oncology,...